KR930013115A - Dna 분자 및 숙주 - Google Patents

Dna 분자 및 숙주 Download PDF

Info

Publication number
KR930013115A
KR930013115A KR1019920024117A KR920024117A KR930013115A KR 930013115 A KR930013115 A KR 930013115A KR 1019920024117 A KR1019920024117 A KR 1019920024117A KR 920024117 A KR920024117 A KR 920024117A KR 930013115 A KR930013115 A KR 930013115A
Authority
KR
South Korea
Prior art keywords
recombinant dna
dna molecule
processing endoprotease
dibasic processing
host cell
Prior art date
Application number
KR1019920024117A
Other languages
English (en)
Other versions
KR100270283B1 (ko
Inventor
챠우드후리 브하바토쉬
스테팡 크리스틴
제에보트 페터
리이쯔맨 하워드
Original Assignee
베르너 발데그
시바-가이기 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베르너 발데그, 시바-가이기 에이지 filed Critical 베르너 발데그
Publication of KR930013115A publication Critical patent/KR930013115A/ko
Application granted granted Critical
Publication of KR100270283B1 publication Critical patent/KR100270283B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 변형되고, 소포체(ER)내에 위치하는 "이염기성 프로세싱 엔도프로테아제"를 함호화하는 DNA분자및 형질전환된 숙주내에서 이종 폴리펩타이드의 정확한 프로세싱을 위한 상기의 소포체내에 위치하는 "이염기성 프로세싱 엔도프로테아제"의 용도에 관한 것이다.

Description

DNA 분자 및 숙주
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (14)

  1. 소포체(ER) 내에 "이염기성 프로세싱 엔도프로테아제'활성을 갖는 숙제 세포를 사용함을 특징으로 하여, 숙주 세포내에서 프로-서열이 절단된 이종 단백질을 제조하는 방법.
  2. 제1항에 있어서, ER내에 위치하는 KEX2 또는 YAP3 프로테아제를 갖는 효모 숙제 제포를 사용하는 방법.
  3. 제1항에 있어서, ER내에 위치하는 KEX2 프로테아제를 갖는 효모 숙주 제포를 사용하는 방법.
  4. 제1항에 있어서, 효모-인자 프로 서열이 절단된 이종의 생물학적으로 활성인 단백질을 제조하는 방법.
  5. 제1항에 있어서, 인슐린-관련된 단백질을 제조하는 방법.
  6. ER내에 위치하는 "이염기성 프로세싱 엔도프로테아제"에 대한 발현 카세트를 암호화하는 재조합 DNA 분자.
  7. 제6항에 있어서, "이염기성 프로세싱 엔도프로테아제"및 ER-보유 시그날로 이루어진 ER내에 위치하는 "이염기성 프로세싱 엔도프로테아제"를 암호화하는 재조합 DNA분자.
  8. 제6항에 있어서, 가용성의 "이염기성 프로세싱 엔도프로테아제" 및 ER-보유 시그날로 이루어진 ER내에 위치하는 '이염기성 프로세싱 엔도프로테아제"를 암호화하는 재조합 DNA 분자.
  9. 제7항에 있어서, KEX2pHDEL, KEX2pSHDEL및 YAP3HDEL로 이루어진 그룹중에서 선택된 단백질을 암호화하는 재조합 DNA 분자.
  10. 제6항에 따른 재조합 DNA 분자를 포함하는 하이브리드 벡터.
  11. 제10항에 따른 하이브리드 벡터로 형질전환된 숙주 세포.
  12. 제11항에 있어서, 안정하게 형질전환된 숙주 세포.
  13. 제6항에 따른 재조합 DNA 분자를 제조하는 방법.
  14. 제11항에 따른 숙주 세표를 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920024117A 1991-12-16 1992-12-14 이염기성 프로세싱 엔도프로테아제를 암호화하는 dna 분자 및 이를 이용하여 이종 단백질을 제조하는 방법 KR100270283B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91810984 1991-12-16
CH91810984.4 1991-12-16
EP91810984.4 1991-12-16

Publications (2)

Publication Number Publication Date
KR930013115A true KR930013115A (ko) 1993-07-21
KR100270283B1 KR100270283B1 (ko) 2000-11-01

Family

ID=8208912

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920024117A KR100270283B1 (ko) 1991-12-16 1992-12-14 이염기성 프로세싱 엔도프로테아제를 암호화하는 dna 분자 및 이를 이용하여 이종 단백질을 제조하는 방법

Country Status (17)

Country Link
US (2) US5501975A (ko)
EP (1) EP0548012B1 (ko)
JP (1) JP3305781B2 (ko)
KR (1) KR100270283B1 (ko)
AT (1) ATE157703T1 (ko)
AU (1) AU667852B2 (ko)
CA (1) CA2085308C (ko)
DE (1) DE69222013T2 (ko)
DK (1) DK0548012T3 (ko)
ES (1) ES2107520T3 (ko)
FI (1) FI105482B (ko)
GR (1) GR3025324T3 (ko)
IL (1) IL104075A (ko)
MX (1) MX9207291A (ko)
NO (1) NO308619B1 (ko)
NZ (1) NZ245469A (ko)
ZA (1) ZA929711B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9404270D0 (en) * 1994-03-05 1994-04-20 Delta Biotechnology Ltd Yeast strains and modified albumins
JPH11500920A (ja) * 1995-02-27 1999-01-26 アボツト・ラボラトリーズ 修飾された組換えタンパク質を細菌系において発現させるプラスミド
US5710044A (en) * 1995-02-27 1998-01-20 Abbott Laboratories Plasmid for expressing phosphorylated recombinant proteins in a bacterial system
US5807702A (en) * 1995-02-27 1998-09-15 Abbott Laboratories Method for expressing phosphorylated recombinant human β-casein in a bacterial system
NZ304538A (en) * 1995-02-27 1999-08-30 Abbott Lab Process for producing a modified recombinant protein in a host cell comprising preparing a single vector encoding both the exogenous protein and an enzyme capable of modifying the exogenous protein
US5942254A (en) * 1995-02-27 1999-08-24 Abbott Laboratories Phosphorylated recombinant human β-casein expressed in a bacterial system
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
ATE408020T1 (de) * 1998-11-06 2008-09-15 Novo Nordisk Healthcare Ag Verfahren zur herstellung von faktor vii
WO2002000856A2 (en) * 2000-06-30 2002-01-03 Flanders Interuniversity Institute For Biotechnology (Vib) Protein glycosylation modification in pichia pastoris
DE10221411B4 (de) * 2002-05-14 2004-07-08 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Rekombinantes Fowlpox-Virus
US20040117874A1 (en) * 2002-10-15 2004-06-17 Jianjun Yang Methods for accumulating translocated proteins
US7507573B2 (en) 2003-11-14 2009-03-24 Vib, Vzw Modification of protein glycosylation in methylotrophic yeast
CA2567599C (en) * 2004-05-21 2015-07-21 Mo Bio Laboratories, Inc. Kits and processes for removing contaminants from nucleic acids in environmental and biological samples
US20080082338A1 (en) * 2006-09-29 2008-04-03 O'neil Michael P Systems and methods for secure voice identification and medical device interface
ES2843679T3 (es) 2013-03-06 2021-07-20 Glaxosmithkline Llc Células hospedadoras y métodos de uso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205404B1 (en) * 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
US5391485A (en) * 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
JP2643968B2 (ja) * 1988-02-03 1997-08-25 サントリー株式会社 Ｋｅｘ２エンドプロテアーゼ及びその製造方法

Also Published As

Publication number Publication date
EP0548012B1 (en) 1997-09-03
ATE157703T1 (de) 1997-09-15
NO924847L (no) 1993-06-17
AU3007192A (en) 1993-06-17
MX9207291A (es) 1993-07-01
KR100270283B1 (ko) 2000-11-01
NO924847D0 (no) 1992-12-15
JP3305781B2 (ja) 2002-07-24
NZ245469A (en) 1995-03-28
NO308619B1 (no) 2000-10-02
FI105482B (fi) 2000-08-31
AU667852B2 (en) 1996-04-18
JPH06197787A (ja) 1994-07-19
ES2107520T3 (es) 1997-12-01
GR3025324T3 (en) 1998-02-27
DK0548012T3 (da) 1998-04-14
EP0548012A1 (en) 1993-06-23
FI925678A0 (fi) 1992-12-14
IL104075A0 (en) 1993-05-13
ZA929711B (en) 1993-06-16
DE69222013T2 (de) 1998-01-29
FI925678A (fi) 1993-06-17
CA2085308A1 (en) 1993-06-17
IL104075A (en) 2003-01-12
US5501975A (en) 1996-03-26
US5618690A (en) 1997-04-08
DE69222013D1 (de) 1997-10-09
CA2085308C (en) 2003-12-02

Similar Documents

Publication Publication Date Title
KR930013115A (ko) Dna 분자 및 숙주
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
DE69434083D1 (de) Expression eines fusionspolypeptides, das ohne leadersequenz aus dem cytoplasma transportiert wird
ATE169959T1 (de) Anthrax-toxin-fusionsproteine und deren verwendungen
ES2092995T3 (es) Metodo para producir celulas conteniendo un adn extraño establemente integrado con un numero alto de copia, las celulas producidas por este metodo y el uso de estas celulas para producir el polipeptido codificado por el adn extraño.
KR880014110A (ko) 인체 프로아포지방단백질 a-i의 발현
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
IL66614A (en) Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
ATE140029T1 (de) Herstellung von biologischaktivem insulinähnlichem wachstumsfaktor i aus hochexpressions-wirtszellsystemen
PT850310E (pt) Molecula de dna circular com origem de replicacao condicional, metodo para a sua preparacao e utilizacao da mesma na terapia genica
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
ATE98686T1 (de) Proteaseresistente urokinase-zusammensetzung, deren herstellung und verwendung.
ATE123949T1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
SE8303626D0 (sv) A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
DK164940C (da) Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
KR950704497A (ko) 글리코실트랜스퍼라제 활성을 가진 단백질(Proteins Having Glycosyltransferase Activity)
DK0434605T3 (da) Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli
KR880001816A (ko) 변이 인간 프로유로키나제 및 이의 제조방법
ATE89317T1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
WO1994003601A8 (en) Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan
KR910018551A (ko) 스트렙토마이세스에서의 외래 단백질의 제조방법
DE69027466D1 (de) Achromobacter-Protease-I-Gen sowie Genprodukt
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
ATE119938T1 (de) Produktion von menschlichen nervenwachstumsfaktoren.

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120628

Year of fee payment: 13

EXPY Expiration of term